Andexanet alfa - what we know about this promising drug

• Main Authors: Natalia Ilnicka (Author), Patrycja Zuziak (Author), Maria Sadlik (Author), Daria Matyja (Author), Leila Abod (Author)
• Format: Knjiga
• Izdano: Kazimierz Wielki University, 2023-09-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Introduction and purpose. Andexanet alfa (AA) is a recombinant modified version of human activated factor X. It is used as an antidote for apixsaban and rivaroxaban when reversal of anticoagulation due to life-threatening or uncontrolled bleeding is necessary. The aim of this paper is to present AA&...